Skip to Content

TEVA 5046 (Dexmethylphenidate Hydrochloride Extended-Release 35 mg)

Pill with imprint TEVA 5046 is Blue & White, Capsule-shape and has been identified as Dexmethylphenidate hydrochloride extended-release 35 mg. It is supplied by Teva Pharmaceuticals USA, Inc..

Dexmethylphenidate is used in the treatment of adhd; auditory processing disorder and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Dexmethylphenidate 35 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for TEVA 5046

Dexmethylphenidate hydrochloride extended-release

Imprint:
TEVA 5046
Strength:
35 mg
Color:
Blue & White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
CNS stimulants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
2 - High potential for abuse
Labeler / Supplier:
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC):
00093-5046

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide